//
Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective
Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI)
Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy
Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease